tsamba_banner

3415-08-5 L-Tyr-NCA

3415-08-5 L-Tyr-NCA

Kufotokozera Kwachidule:

Maonekedwe Zoyera mpaka Zoyera-zoyera kapena ufa wa crystalline
MF C10H9NO4
MW 207.18
Chiyero 98+


Tsatanetsatane wa Zamalonda

Mayendedwe&njira yotumizira yovomerezeka:
pamlengalenga, panyanja kapena panjira

Malo osungira:
nert atmosphere, Sungani mufiriji, pansi -20°C

Mtengo Wocheperako:
Kukambilana

Chitsimikizo:
COA, HPLC, GC, HNMR, Assay, Water Content(KF), TLC zilipo

D-Ls(tfa)-NCA (2)

Mawu ofanana ndi mawu

Tyrosine, NCA;

N-Carboxy-L-tyrosine anhydride;

(4S) -4- [(4-Hydroxyphenyl)methyl]-2,5-oxazolidinedione;

L-Tyrosine N-carboxyanhydride;

(2,5-Oxazolidinedione,4- [(4-hydroxyphenyl)Methyl]-, (4S)-;

N-Carbonyl-L-Tyrosine Anhydride

Kupaka mkati

Nthawi zambiri amagwiritsidwa ntchito kunyamula ufa.Ndipo angathandize kuti dzuwa ndi madzi zisawonongeke.

Kupaka mkati 2
Kupaka mkati 1
Kupaka mkati 3

kulongedza kwakunja

Katoni yolimba imatha kuteteza zinthu zanu kuti zisawonongeke ndikunyowa.

Kupaka kunja 3
Kupaka kunja 2
Kupaka kunja 1

Mapulogalamu

3415-08-5 L-Tyr-NCA ndi amodzi mwa apakati a Glatiramer Acetate.

Glatiramer Acetate ndi peptide yokonzekera yopangidwa ndi ma amino acid anayi: glutamic acid, alanine, tyrosine, ndi lysine.Ntchito yake yayikulu ndikuchiza Multiple Sclerosis (MS), matenda osatha, otupa, ochotsa miyelin omwe amakhudza dongosolo lapakati lamanjenje.Kupyolera mu njira ya "bypass kupondereza," Glatiramer Acetate imakhala ndi zotsatira zowononga thupi komanso zotsutsana ndi zotupa mu MS, kuonjezera milingo ya neurotrophic factor (BDNF) yochokera muubongo, kuchepetsa kutupa komwe kumayambitsa kutulutsa magazi, komanso kulimbikitsa kukula kwa ma axon ndi ma myelin sheaths.

Padziko lonse lapansi, Glatiramer Acetate yapeza ntchito zambiri.Mwachitsanzo, ku United States, imagulitsidwa pansi pa dzina la Copaxone ndipo yavomerezedwa ndi Food and Drug Administration (FDA) pochiza Multiple Sclerosis.M'mayiko a Kumadzulo omwe ali ndi vuto lalikulu la MS, mphamvu zake komanso kulekerera kwake zadziwika kwambiri.

Ku China, pa June 28, 2023, "Glatiramer Acetate Injection" idalandira chilolezo kuchokera ku National Medical Products Administration (NMPA) kuti athe kuchiza odwala omwe ali ndi matenda a Multiple Sclerosis (MS), kuphatikizapo matenda akutali, obwereranso. MS, ndi yogwira sekondale patsogolo MS.

zokhudzana ndi mankhwala

L-Gly-NCA L-Ala-NCA D-Ala-NCA L-Val-NCA
D-Leu-NCA DL-leu-NCA L-Phe-NCA D-Tyr-NCA
L-Tyr(bzl)-NCA L-Glu(Obzl)-NCA D-Asp(OBzl)-NCA L-Lys(tfa)-NCA
L-Ls(Cbz)-NCA D-Ls(Cbz)-NCA Sar-NCA

Kuposa

1. Ntchito ya R&D ilipo
2. Wopanga wovomerezeka wa ISO, chitsimikizo chamtundu
3.Njira yokwanira yotsatila ntchito panthawi yopanga
4.Kukwera mtengo kwambiri
5.Quality certification zikalata zoperekedwa pa pempho kasitomala
6.Great pambuyo-malonda utumiki, kusunga ubale wapamtima ndi kasitomala
7.Chithandizo chonse chothandizira kuchepetsa ndalama zotumizira
Chitsanzo cha 8.Free choperekedwa kuti chiyang'ane khalidwe musanapereke malipiro
9.Payment term kukambirana
Makasitomala a 10.Assit amakumana ndi zochitika ku China


  • Zam'mbuyo:
  • Ena:

  • Lembani uthenga wanu apa ndikutumiza kwa ife